Interesting Articles

Angie Szumlinski
|
May 2, 2022

Anxiety May Amplify Risk of Cognitive Impairment

Angie Szumlinski
|
May 2, 2022

U.S. FDA Approves Pfizer’s XELJANZ (tofacitinib) for the Treatment of Active Ankylosing Spondylitis

Andrea Haupt
|
April 25, 2022

Methylphenidate Treats Apathy in Alzheimer Disease

Andrea Haupt
|
April 25, 2022

Statin Use is Associated with Diabetes Progression